ReviewJournal of experimental pharmacology2012

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.

Randall E Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.